百博生物 (830774.OC)

+ 收藏

财务分析(报告期)(百博生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报2022年一季报
主要指标:
 营业收入(元) 16,175,883.1634,203,640.3319,082,637.94128,554,741.8073,414,348.2951,001,134.20
 营业利润(元) 130,578.71-9,190,262.68-671,234.8310,288,206.7513,830,152.8613,677,274.92
 利润总额(元) 991,415.02-8,405,430.47-958,797.3510,839,477.2714,441,453.5414,277,275.60
 净利润(元) 991,253.40-8,381,052.22-958,797.3510,048,107.7312,368,707.4712,488,466.09
 归属于母公司股东的净利润(元) 991,253.40-8,381,052.22-958,797.3510,048,107.7312,368,707.4712,488,466.09
盈利能力:
 销售毛利率(%) 41.5937.2634.9726.7535.2540.68
 销售净利率(%) 6.13-24.50-5.027.8216.8524.49
 净资产收益率(%) 0.91-7.70-0.97---
 总资产报酬率ROA(%) 0.92-6.29-0.67---
 投入资本回报率ROIC(%) 1.02-6.69-0.5510.0613.5013.44
营运能力:
 存货周转率(次) 0.962.050.65---
 应收账款周转率(次) 3.606.233.67---
 总资产周转率(次) 0.130.270.16---
偿债能力:
 资产负债率(%) 11.3112.2612.6316.5521.0221.58
 股东权益比率(%) 88.6987.7487.3783.4578.9878.42
 已获利息倍数(倍) 7.84-20.54-4.8721.2683.9992.08
 流动比率 12.0710.8210.978.717.075.40
 速动比率 10.569.418.576.933.553.61
发展能力:
 营业收入增长率(%) -15.23-73.39-74.0166.67115.6995.73
 营业利润增长率(%) 119.45-189.33-104.85-31.33118.2690.19
 税后利润增长率(%) 203.39-183.41-107.75-28.33131.66103.40
 净资产增长率(%) -5.67-7.3531.2744.9123.16-
 总资产增长率(%) -7.08-11.8918.6839.5928.07-

前瞻产业研究院